ask our doctors

Sarcoma

Get the facts on Sarcoma treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Sarcoma prevention, screening, research, statistics and other Sarcoma related topics. We answer all your qestions about Sarcoma.

Question: Anyone know much about synovial sarcoma and whether it is a serious cancer? what are the chance of a sarcoma coming back because i have been given the all clear after bieng diognosed over a year ago with synovial sarcoma to the neck.... grade 2.

Answer: What is synovial sarcoma? Synovial sarcoma is a type of soft tissue sarcoma. Soft tissue sarcomas are cancers of the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body, including synovial tissue. Synovial tissue lines the cavities of joints, such as the knee or elbow, tendons (tissues that connect muscle to bone), and bursae (fluid-filled, cushioning sacs in the spaces between tendons, ligaments, and bones). Although synovial sarcoma does not have a clearly defined cause, genetic factors are believed to influence the development of this disease. How often does synovial sarcoma occur? Synovial sarcoma is rare. It accounts for between 5 and 10 percent of the approximately 10,000 new soft tissue sarcomas reported each year (1). Synovial sarcoma occurs mostly in young adults, with a median age of 26.5 (1). Approximately 30 percent of patients with synovial sarcoma are younger than 20. This disease occurs more often in men than in women (1). Where does synovial sarcoma develop? About 50 percent of synovial sarcomas develop in the legs, especially the knees. The second most common location is the arms (2). Less frequently, the disease develops in the trunk, head and neck region, or the abdomen (1, 2). It is common for synovial cancer to recur (come back), usually within the first two years after treatment. Half of the cases of synovial sarcoma metastasize (spread to other areas of the body) to the lungs, lymph nodes, or bone marrow (1). What are the symptoms of synovial sarcoma? Synovial sarcoma is a slow-growing tumor. Because it grows slowly, a person may not have or notice symptoms for some time, resulting in a delay in diagnosis. The most common symptoms of synovial sarcoma are swelling or a mass that may be tender or painful (1). The tumor may limit range of motion or press against nerves and cause numbness. The symptoms of synovial sarcoma can be mistaken for those of inflammation of the joints, the bursae, or synovial tissue. These noncancerous conditions are called arthritis, bursitis, and synovitis, respectively. How is synovial sarcoma diagnosed? The doctor may use the following procedures and tests to diagnose synovial sarcoma: Biopsy: Tissue is removed for examination under a microscope. Immunohistochemical analysis: Tumor tissue is tested for certain antigen and antibody interactions common to synovial sarcoma. Ultrastructural findings: The tissue is examined using an ultramicroscope and electron microscope. Genetic testing: Tissue is tested for a specific chromosome abnormality common to synovial sarcoma. How is synovial sarcoma treated? The type of treatment depends on the age of the patient, the location of the tumor, its size, its grade (how abnormal the cancer cells look under a microscope and how likely the tumor will quickly grow and spread), and the extent of the disease. The most common treatment is surgery to remove the entire tumor with negative margins (no cancer cells are found at the edge or border of the tissue removed during surgery). If the first surgery does not obtain negative tissue margins, a second surgery may be needed. The patient may also receive radiation therapy before or after surgery to control the tumor or decrease the chance of recurrence (cancer coming back). The use of intraoperative radiation therapy (radiation aimed directly at the tumor during surgery) and brachytherapy (radioactive material sealed in needles, wires, seeds, or catheters, and placed directly into or near a tumor) are under study. Patients may also receive chemotherapy alone or in combination with radiation therapy


Sarcoma News

Sarcoma Alliance seeks volunteers across the country

San Francisco Chronicle (press release)
The Sarcoma Alliance gives education, guidance and support to people affected by the rare cancer called sarcoma, and it has found people want to give back, board member Alison Olig said today. "The Alliance has amazing, committed volunteers, ...
 

Proactive Investors USA & Canada

Threshold lands $25M upfront, possible $525M more, in cancer drug deal
Bizjournals.com (blog)
 

Hinsey helps lead Wakulla wrestlers to district title

Tallahassee.com
Wakulla's Travis Hinsey overcame Ewing's sarcoma and won a district championship at 138 pounds Saturday night. / Special to the Democrat By Mike Stella Wakulla's Travis Hinsey is all the way back. The senior wrestler captured his first district title ...
 

Merck Gives Grant to Sarcoma Alliance to Update Peer-to-Peer Network

San Francisco Chronicle (press release)
By Internet and phone, the national nonprofit organization connects people with a rare cancer called sarcoma. The grant will go for software and printing expenses. "Thank God the Sarcoma Alliance has this program," says Sarah of St. Cloud, Fla.
 

NBCSports.com

Mark Cuban donates $75K to 1 Million 4 Anna
ESPN (blog)
 

Midwest Sports Fans

Mark Herzlich Beats Cancer, Tweets Inspiration, and Authors The Best Story of ...
Midwest Sports Fans
 

University of Michigan Health System News (press release)

UM researcher receives grant to develop new approaches to treat Ewing's sarcoma
University of Michigan Health System News (press release)
 

Sydney Morning Herald

Patch Notes & Quotes from Super Bowl XLVI
Patch.com
 

Letters: sarcoma the killer, Thompson the chief, smoking ban $$$ and more?.

Easy Reader
I wanted to let the South Bay community know, and to let his family know, that sarcoma cancers are indeed rare, aggressive cancers that often metastasize before a specialist has a chance to diagnose and hopefully treat the disease.
 

Prognostic factors for retroperitoneal sarcoma diminish after 1 year

HemOncToday
Tumor and patient characteristics that can predict prognosis after resection of retroperitoneal sarcoma lose their significance after 1 year of survival, according to study findings published in Cancer. Researchers used SEER registries to conduct a ...